This webinar will be led by Dr Elizabeth Ratcliffe and will focus on the role of dedicated Barrett’s Oesophagus Services and how to detect dysplasia/early cancer. It will also cover what future surveillance might look like and include updates from the BOSS Trial.
Suitable for: Gastroenterologists, Surgeons, Clinical Endoscopists, Nurse Endoscopists, Registrars, any staff conducting OGD’s within their clinical practice.